Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 80

Published Date: 06 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global demand for poultry products such as chicken and eggs continues to grow owing to factors such as population growth, increasing disposable income, and changing dietary preferences. This increased demand requires healthier and more efficient poultry farming methods, including vaccinations to prevent disease.

Chicken embryos were inoculated with chicken embryos mixed with chicken newcastle virus ii strains and chicken pox virus weak strains, chicken infectious bronchitis virus H120 strains were inoculated with chicken embryos alone, chicken embryo solution and villurionic allantouria membrane were harvested, homogenized in a certain proportion, stabilizer was added, and dried by freezing vacuum.

This report studies the global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine total production and demand, 2018-2029, (Box)
Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine total production value, 2018-2029, (USD Million)
Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Box)
Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine consumption by region & country, CAGR, 2018-2029 & (Box)
U.S. VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine domestic production, consumption, key domestic manufacturers and share
Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Box)
Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Box)
Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (Box).

This reports profiles key players in the global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Pulike and Luoyang Huizhong Biotechnology Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Box) and average price (US$/Box) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market, Segmentation by Type
    Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live
    Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated

Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market, Segmentation by Application
    Veterinary Drug
    Scientific Research

Companies Profiled:
    Boehringer Ingelheim
    Pulike
    Luoyang Huizhong Biotechnology Co., Ltd.

Key Questions Answered
1. How big is the global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market?
2. What is the demand of the global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market?
3. What is the year over year growth of the global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market?
4. What is the production and production value of the global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market?
5. Who are the key producers in the global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Introduction
    1.2 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Supply & Forecast
        1.2.1 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2029)
        1.2.3 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Pricing Trends (2018-2029)
    1.3 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Region (Based on Production Site)
        1.3.1 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Region (2018-2029)
        1.3.2 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Region (2018-2029)
        1.3.3 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2029)
        1.3.5 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2029)
        1.3.6 China Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2029)
        1.3.7 Japan Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Major Market Trends

2 Demand Summary
    2.1 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Demand (2018-2029)
    2.2 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption by Region
        2.2.1 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption by Region (2018-2023)
        2.2.2 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029)
    2.4 China Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029)
    2.5 Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029)
    2.6 Japan Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029)
    2.7 South Korea Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029)
    2.8 ASEAN Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029)
    2.9 India Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029)

3 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers Competitive Analysis
    3.1 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Manufacturer (2018-2023)
    3.3 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine in 2022
    3.6 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market: Region Footprint
        3.6.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market: Company Product Type Footprint
        3.6.3 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Comparison
        4.1.1 United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Comparison
        4.2.1 United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption Comparison
        4.3.1 United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2023)
    4.5 China Based Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers and Market Share
        4.5.1 China Based Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2023)
    4.6 Rest of World Based Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live
        5.2.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated
    5.3 Market Segment by Type
        5.3.1 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Type (2018-2029)
        5.3.2 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Type (2018-2029)
        5.3.3 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Veterinary Drug
        6.2.2 Scientific Research
    6.3 Market Segment by Application
        6.3.1 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Application (2018-2029)
        6.3.2 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Application (2018-2029)
        6.3.3 World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Boehringer Ingelheim
        7.1.1 Boehringer Ingelheim Details
        7.1.2 Boehringer Ingelheim Major Business
        7.1.3 Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product and Services
        7.1.4 Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Boehringer Ingelheim Recent Developments/Updates
        7.1.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.2 Pulike
        7.2.1 Pulike Details
        7.2.2 Pulike Major Business
        7.2.3 Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product and Services
        7.2.4 Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Pulike Recent Developments/Updates
        7.2.6 Pulike Competitive Strengths & Weaknesses
    7.3 Luoyang Huizhong Biotechnology Co., Ltd.
        7.3.1 Luoyang Huizhong Biotechnology Co., Ltd. Details
        7.3.2 Luoyang Huizhong Biotechnology Co., Ltd. Major Business
        7.3.3 Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product and Services
        7.3.4 Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Luoyang Huizhong Biotechnology Co., Ltd. Recent Developments/Updates
        7.3.6 Luoyang Huizhong Biotechnology Co., Ltd. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Industry Chain
    8.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Upstream Analysis
        8.2.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Mode
    8.6 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Procurement Model
    8.7 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Industry Sales Model and Sales Channels
        8.7.1 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Model
        8.7.2 Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Region (2018-2023) & (Box)
    Table 7. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Region (2024-2029) & (Box)
    Table 8. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Region (2018-2023) & (US$/Box)
    Table 11. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Region (2024-2029) & (US$/Box)
    Table 12. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Major Market Trends
    Table 13. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Box)
    Table 14. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption by Region (2018-2023) & (Box)
    Table 15. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption Forecast by Region (2024-2029) & (Box)
    Table 16. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Producers in 2022
    Table 18. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Manufacturer (2018-2023) & (Box)
    Table 19. Production Market Share of Key Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Producers in 2022
    Table 20. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Manufacturer (2018-2023) & (US$/Box)
    Table 21. Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Company Evaluation Quadrant
    Table 22. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Site of Key Manufacturer
    Table 24. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market: Company Product Type Footprint
    Table 25. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market: Company Product Application Footprint
    Table 26. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Competitive Factors
    Table 27. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Comparison, (2018 & 2022 & 2029) & (Box)
    Table 31. United States VS China Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (Box)
    Table 32. United States Based Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2023) & (Box)
    Table 36. United States Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share (2018-2023)
    Table 37. China Based Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2023) & (Box)
    Table 41. China Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2023) & (Box)
    Table 46. Rest of World Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share (2018-2023)
    Table 47. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Type (2018-2023) & (Box)
    Table 49. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Type (2024-2029) & (Box)
    Table 50. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Type (2018-2023) & (US$/Box)
    Table 53. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Type (2024-2029) & (US$/Box)
    Table 54. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Application (2018-2023) & (Box)
    Table 56. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production by Application (2024-2029) & (Box)
    Table 57. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Application (2018-2023) & (US$/Box)
    Table 60. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Application (2024-2029) & (US$/Box)
    Table 61. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 62. Boehringer Ingelheim Major Business
    Table 63. Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product and Services
    Table 64. Boehringer Ingelheim Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Boehringer Ingelheim Recent Developments/Updates
    Table 66. Boehringer Ingelheim Competitive Strengths & Weaknesses
    Table 67. Pulike Basic Information, Manufacturing Base and Competitors
    Table 68. Pulike Major Business
    Table 69. Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product and Services
    Table 70. Pulike Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Pulike Recent Developments/Updates
    Table 72. Luoyang Huizhong Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 73. Luoyang Huizhong Biotechnology Co., Ltd. Major Business
    Table 74. Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Product and Services
    Table 75. Luoyang Huizhong Biotechnology Co., Ltd. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (Box), Price (US$/Box), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 76. Global Key Players of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Upstream (Raw Materials)
    Table 77. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Typical Customers
    Table 78. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Typical Distributors
List of Figure
    Figure 1. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Picture
    Figure 2. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2029) & (Box)
    Figure 5. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price (2018-2029) & (US$/Box)
    Figure 6. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2029) & (Box)
    Figure 9. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2029) & (Box)
    Figure 10. China Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2029) & (Box)
    Figure 11. Japan Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production (2018-2029) & (Box)
    Figure 12. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029) & (Box)
    Figure 15. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029) & (Box)
    Figure 17. China Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029) & (Box)
    Figure 18. Europe Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029) & (Box)
    Figure 19. Japan Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029) & (Box)
    Figure 20. South Korea Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029) & (Box)
    Figure 21. ASEAN Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029) & (Box)
    Figure 22. India Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption (2018-2029) & (Box)
    Figure 23. Producer Shipments of Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Markets in 2022
    Figure 26. United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share 2022
    Figure 32. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share by Type in 2022
    Figure 34. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Live
    Figure 35. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine, Inactivated
    Figure 36. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Type (2018-2029) & (US$/Box)
    Figure 39. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share by Application in 2022
    Figure 41. Veterinary Drug
    Figure 42. Scientific Research
    Figure 43. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Market Share by Application (2018-2029)
    Figure 44. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Production Value Market Share by Application (2018-2029)
    Figure 45. World Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Average Price by Application (2018-2029) & (US$/Box)
    Figure 46. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Industry Chain
    Figure 47. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Procurement Model
    Figure 48. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Model
    Figure 49. Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Boehringer Ingelheim
Pulike
Luoyang Huizhong Biotechnology Co., Ltd.

Related Reports

Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>